Posted inTechnology News ACC 21: mavacamten improves health status in symptomatic hypertrophic cardiomyopathy Posted by 5 April 2022 NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Pharmaceutical Technology Weekly Roundup. A weekly roundup of the … View All Posts Post navigation Previous Post Change Healthcare and Optum Extend Merger Agreement – UnitedHealth GroupNext PostElon Musk’s Twitter investment puts a 150% rally into play for Dogecoin